|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Transition service agreement income | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Amortization of purchased intangible assets | |||||
| Restructuring costs, net | |||||
| Asset impairments | |||||
| Continuing Operations | |||||
| Total asset impairments | |||||
| Other | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Other income (expense), net | |||||
| Interest expense | |||||
| Interest income | |||||
| Income (loss) from continuing operations before income taxes | |||||
| Income tax (expense) benefit | |||||
| Income (loss) from continuing operations | |||||
| Income (loss) from discontinued operations, net of income tax (expense) benefit of $865.1, $(213.6) and $99.6, respectively | |||||
| Net income (loss) | |||||
| Series A convertible preferred stock dividends | |||||
| Net income (loss) attributable to common stockholders | |||||
| Basic: | |||||
| Earnings (loss) from continuing operations per share | |||||
| Earnings (loss) from discontinued operations per share | |||||
| Earnings (loss) per share | |||||
| Diluted: | |||||
| Earnings (loss) from continuing operations per share | |||||
| Earnings (loss) from discontinued operations per share | |||||
| Earnings (loss) per share | |||||
| Weighted average shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...